Authors
Latest:
Dr Sampalis: What I wish I knew before entering optometryMaria Sampalis, OD, shares what she wishes she knew before entering the field.
Latest:
Opening our eyes to the impact of preservativesPreservatives may disrupt the ocular surface, contributing to poor adherence.
Latest:
How to treat patients with delusional parasitosisDelusional parasitosis or Ekbom’s syndrome is a patient’s mistaken belief that he is infested by parasites such as mites, lice, fleas, spiders, worms, bacteria, or other organisms. Scott Schachter, OD, discusses the challenges ODs face when working with these patients.
Latest:
How to manage adenoviral conjunctivitisAdenoviral conjunctivitis (Ad-CS) has never been so popular a topic as it is right now. With over 26 million viewers tuning in to watch the Olympics, Americans have watched Bob Costas’s unilateral conjunctivitis worsen, then become bilateral. His ocular condition prompted many commentators to remark, “Can’t someone help him?”
Latest:
How to manage adenoviral conjunctivitisAdenoviral conjunctivitis (Ad-CS) has never been so popular a topic as it is right now. With over 26 million viewers tuning in to watch the Olympics, Americans have watched Bob Costas’s unilateral conjunctivitis worsen, then become bilateral. His ocular condition prompted many commentators to remark, “Can’t someone help him?”
Latest:
AAOpt 2022: Understanding antibiotics: the how and when to prescribeBlair Lonsberry, MS, OD, MEd, FAAO, shares highlights from his 2022 American Academy of Optometry presentation, "Simplifying systemic antibiotics."
Latest:
Lifitegrast improves clinical signs and biomarkers of patients with DED: A Q&A with Dr. James ThimonsAll 6 biomarkers in the study demonstrated improvement with the treatment of lifitegrast, according to Thimons.
Latest:
Back to the basics: The importance of treating inflammation AND obstruction for dry eyeDerek Cunningham, OD, FAAO, gives key takeaways from his AAOpt 2022 discussion, "Back to the basics: The importance of treating inflammation AND obstruction for dry eye."
Latest:
New Opportunities in Topical Glaucoma ManagementA newer class of topical glaucoma therapy, Rho kinase inhibitors, works to lower intraocular pressure in patients with glaucoma via a novel mechanism. In this podcast, Mitch Ibach, OD, FAAO, of Vance Thompson Vision in Sioux Falls, SD, and Jessica Steen, OD, FAAO, of the Nova Southeastern University College of Optometry in Fort Lauderdale, FL, will discuss the mechanism of action of these agents, along with data supporting their use within the broader range of topical glaucoma therapies.
Latest:
A Future for Remote Monitoring Centers in Eye DiseaseEnthusiasm regarding the acceleration of technology advances, including retinal monitoring centers, that can be used to help prevent disease progression for patients with eye diseases.
